2016 News Releases
A UT Southwestern Medical Center study comparing two types of materials used in abdominal wall hernia repair surgery found no evidence to support the use of costlier biologic mesh versus synthetic mesh.
HPV vaccination is our best defense in stopping HPV infection in our youth and preventing HPV-related cancers in our communities.
UT Southwestern Medical Center researchers have deciphered how a small protein made by the human immunodeficiency virus (HIV) that causes AIDS manipulates human genes to further its deadly agenda.
UT Southwestern Medical Center chemists have successfully used synthetic nanoparticles to deliver tumor-suppressing therapies to diseased livers with cancer, an important hurdle scientists have been struggling to conquer.
Tumor-suppressing gene works by restraining mobile genetic elements that can lead to genomic instability
The most commonly mutated gene in cancer, p53, works to prevent tumor formation by keeping mobile elements in check that otherwise lead to genomic instability, UT Southwestern Medical Center researchers have found.
Study identifies how certain drugs alter the metabolism of pancreatic cancer cells, revealing a new therapeutic target
UT Southwestern Medical Center researchers have found that cancer drugs known as CDK4/6-inhibitors alter the metabolism of pancreatic cancer cells, revealing a biologic vulnerability that could be exploited for therapeutic gain.
Dr. James K.V. Willson, Associate Dean of Oncology Programs, and Professor and Director of the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern Medical Center, has been named Chief Scientific Officer of CPRIT.
Pediatric researchers at UT Southwestern Medical Center have identified a key component of the pathogenesis of bronchopulmonary dysplasia (BPD), a devastating and sometimes fatal lung disease that affects premature infants.
Researchers at UT Southwestern Medical Center have identified a previously unrecognized small protein in cells of the human heart that plays a key role in heart muscle contraction.
UT Southwestern clinical trial reveals effective, targeted therapy for inner-city children and adolescents with chronic asthma
More effective treatment may be on the horizon for young chronic asthma sufferers living in urban areas, based on clinical trial findings that identified a targeted therapy to reduce severe asthma flare-ups.